Carbohydrate‐Based Drug Discovery 2003
DOI: 10.1002/3527602437.ch1
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic Methodologies

Abstract: The first description of glycosaminoglycans (GAGs) was by J. Mçller in 1836, who isolated ªchondrinº, a sugar-related substance from cartilage that was later shown to contain a sulfo group by Maerner (1889) and renamed ªchondroitsåureº [1]. It was not until 1935 that Karl Meyer discovered hyaluronic acid, initiating the exploration of GAG biochemistry and the identification of different types of GAGs. The past half-century has resulted in substantial progress in the elucidation of GAG fine structure, biosynthe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 236 publications
(311 reference statements)
0
1
0
Order By: Relevance
“…Participating in such interactions are α-glycoside epitopes, found on bacteria, e.g., Mycoplasma , and on numerous mammalian oligosaccharides, for instance sialyl Lewis X (sLe x ). The synthesis of oligosaccharide ligands as potential inhibitors, however, remains laboriously demanding [ 8 , 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…Participating in such interactions are α-glycoside epitopes, found on bacteria, e.g., Mycoplasma , and on numerous mammalian oligosaccharides, for instance sialyl Lewis X (sLe x ). The synthesis of oligosaccharide ligands as potential inhibitors, however, remains laboriously demanding [ 8 , 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%